TY - JOUR
T1 - Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma
AU - Koot, Anna
AU - Soares, Paula
AU - Robenshtok, Eyal
AU - Locati, Laura D.
AU - de la Fouchardiere, Christelle
AU - Luster, Markus
AU - Bongiovanni, Massimo
AU - Hermens, Rosella
AU - Ottevanger, Petronella
AU - Geenen, Frans
AU - Bartѐs, Beate
AU - Rimmele, Harald
AU - Durante, Cosimo
AU - Nieveen-van Dijkum, Els
AU - Stalmeier, Peep
AU - Dedecjus, Marek
AU - Netea-Maier, Romana
N1 - Funding Information: This work was supported by the This work was supported by the EORTC. The first author (AK) was funded by the Dutch Cancer Society (grant number 11463 ). Publisher Copyright: © 2022 The Authors
PY - 2023/1/1
Y1 - 2023/1/1
N2 - The incidence of differentiated thyroid cancer (DTC) has been increasing worldwide, mostly, as an increase in the incidental detection of micro papillary thyroid carcinomas (microPTCs), many of which are potentially overtreated, as suggested by the unchanged mortality. Several international guidelines have suggested a less aggressive approach. More recently, it has been shown that active surveillance or minimally invasive treatments (MIT) are good alternatives for the management of these patients. In this context, patient participation in the decision-making process is paramount. The Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) has undertaken the task to establish consensus and define its position based on the scientific evidence concerning, 1) the current state of diagnostic and management options in microPTCs, including the current opinion of physicians about shared decision making (SDM), 2) the available evidence concerning patients' needs and the available decision instruments, and 3) to provide practical suggestions for implementation of SDM in this context. To improve SDM and patients' participation, knowledge gaps and research directions were highlighted.
AB - The incidence of differentiated thyroid cancer (DTC) has been increasing worldwide, mostly, as an increase in the incidental detection of micro papillary thyroid carcinomas (microPTCs), many of which are potentially overtreated, as suggested by the unchanged mortality. Several international guidelines have suggested a less aggressive approach. More recently, it has been shown that active surveillance or minimally invasive treatments (MIT) are good alternatives for the management of these patients. In this context, patient participation in the decision-making process is paramount. The Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) has undertaken the task to establish consensus and define its position based on the scientific evidence concerning, 1) the current state of diagnostic and management options in microPTCs, including the current opinion of physicians about shared decision making (SDM), 2) the available evidence concerning patients' needs and the available decision instruments, and 3) to provide practical suggestions for implementation of SDM in this context. To improve SDM and patients' participation, knowledge gaps and research directions were highlighted.
KW - Microcarcinoma
KW - Papillary
KW - Shared decision making
KW - Thyroid
KW - Treatment options
UR - http://www.scopus.com/inward/record.url?scp=85143982512&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.ejca.2022.11.005
DO - https://doi.org/10.1016/j.ejca.2022.11.005
M3 - Article
C2 - 36521335
SN - 0959-8049
VL - 179
SP - 98
EP - 112
JO - European Journal of Cancer
JF - European Journal of Cancer
ER -